Skip to main content

Advertisement

ADVERTISEMENT

Volume 30 - Issue 12 - December 2022

Featured Article

Acute Venous Intervention
12/01/2022

CLD talks with Michael Lichtenberg, MD, FESC

Chief Medical Officer, Angiology Department, Vascular Centre Clinic, Arnsberg, Germany

CLD talks with Michael Lichtenberg, M...
I think the greatest advantage of the Aspirex™ Thrombectomy System is its simplicity. You can just turn it on and aspirate the thrombus out. 
I think the greatest advantage of the Aspirex™ Thrombectomy System is its simplicity. You can just turn it on and aspirate the thrombus out. 
I think the greatest advantage...
12/01/2022
Cath Lab Digest

Department

Meeting Update
01/13/2023
This program is targeted toward staff who are new to the cath lab setting.
This program is targeted toward staff who are new to the cath lab setting.
This program is targeted toward...
01/13/2023
Cath Lab Digest
Meeting Update
01/09/2023

Kusum Lata, MD, FACC, FSCAI

Interventional Cardiology, Cardiology & Vascular Disease, Sutter Health; Vice Chair, Board of Directors, Sutter Gould Medical Group, Tracy, California


Anna Beyer, MD

Interventional Cardiology, University of California, at San Francisco, San Francisco, California


For more information, email Anna Beyer at Anna.Beyer@ucsf.edu or Kusum Lata at latak1@sutterhealth.org.

Kusum Lata, MD, FACC, FSCAI Interven...
We have initiated a quarterly meeting for Northern California Women in Interventional Cardiology. Our inaugural meeting was held November 4, 2022, and featured an introduction from Society for Cardiovascular Angiography and Interventions...
We have initiated a quarterly meeting for Northern California Women in Interventional Cardiology. Our inaugural meeting was held November 4, 2022, and featured an introduction from Society for Cardiovascular Angiography and Interventions...
We have initiated a quarterly...
01/09/2023
Cath Lab Digest

Insights

CLD Discussion with Drs Kern & Lim
01/03/2023

A discussion with CLD's Clinical Editor Morton J. Kern, MD, and Michael J. Lim, MD.

A discussion with CLD's Clinical Edit...
Morton J. Kern, MD, and Michael J. Lim, MD, discuss the latest topics in the cath lab.
Morton J. Kern, MD, and Michael J. Lim, MD, discuss the latest topics in the cath lab.
Morton J. Kern, MD, and Michael...
01/03/2023
Cath Lab Digest
Out-of-Hospital Care
12/31/2022

Timothy Dao, MD, FACC; Rikesh Patel, MD, FACC, HeartPlace, Plano, Texas

Timothy Dao, MD, FACC; Rikesh Patel, ...
CLD talks with Timothy Dao, MD, FACC, and Rikesh Patel, MD, FACC about their practice and the best-in-class technology they utilize to provide high-quality cardiac care.
CLD talks with Timothy Dao, MD, FACC, and Rikesh Patel, MD, FACC about their practice and the best-in-class technology they utilize to provide high-quality cardiac care.
CLD talks with Timothy Dao, MD,...
12/31/2022
Cath Lab Digest

Column

Clinical Editor's Corner
12/02/2022

Morton J. Kern, MD, MSCAI, FACC, FAHA

Clinical Editor; Chief of Cardiology, Long Beach VA Medical Center, Long Beach, California; Professor of Medicine, University of California, Irvine Medical Center, Orange, California

Morton J. Kern, MD, MSCAI, FACC, FAHA...
Working in the cardiac cath lab (or any medical unit) is a team sport. To improve efficiency and safety in the lab, team members attended a Cultural Team Training.
Working in the cardiac cath lab (or any medical unit) is a team sport. To improve efficiency and safety in the lab, team members attended a Cultural Team Training.
Working in the cardiac cath lab...
12/02/2022
Cath Lab Digest

Feature

Clinical Update
12/01/2022

CLD talks with:

• ARCH Trial Senior Investigator Professor R. H. Stables, MA (Cantab) DM Oxon BM BCh (Oxon) FRCP (London);

• STAT2 Trial Principal Investigators Jordan G. Safirstein, MD, and Arnold H. Seto, MD, MPA.

CLD talks with: • ARCH Trial Senior ...
Not only does StatSeal achieve hemostasis in less time, but it did so in a remarkably consistent manner across the entire population. We can be certain that we will not have hemostasis problems by two hours and confidently use an expedited...
Not only does StatSeal achieve hemostasis in less time, but it did so in a remarkably consistent manner across the entire population. We can be certain that we will not have hemostasis problems by two hours and confidently use an expedited...
Not only does StatSeal achieve...
12/01/2022
Cath Lab Digest

Advertisement

Advertisement

Advertisement